BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15114576)

  • 1. Origin of diastereoselection in the hydrosilylation of chiral N-acyliminium intermediates derived from pyroglutamic acid.
    Oba M; Koguchi S; Nishiyama K; Kaneno D; Tomoda S
    Angew Chem Int Ed Engl; 2004 Apr; 43(18):2412-5. PubMed ID: 15114576
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of quaternary stereogenic centres via stereoselective intermolecular Friedel-Crafts reactions.
    Ball JC; Gleave R; Jones S
    Org Biomol Chem; 2011 Jun; 9(11):4353-60. PubMed ID: 21505705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective synthesis of conformationally constrained omega-amino acid analogues from pyroglutamic acid.
    Bentz EL; Goswami R; Moloney MG; Westaway SM
    Org Biomol Chem; 2005 Aug; 3(15):2872-82. PubMed ID: 16032366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of ( 2S, 4S)-4-phenylamino-5-oxoproline derivatives.
    Nizova IA; Krasnov VP; Levit GL; Kodess MI
    Amino Acids; 2002; 22(2):179-86. PubMed ID: 12395185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spirocyclic systems derived from pyroglutamic acid.
    Cowley AR; Hill TJ; Kocis P; Moloney MG; Stevenson RD; Thompson AL
    Org Biomol Chem; 2011 Oct; 9(20):7042-56. PubMed ID: 21858317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expeditious access to unprotected racemic pyroglutamic acids.
    Isaacson J; Gilley CB; Kobayashi Y
    J Org Chem; 2007 May; 72(10):3913-6. PubMed ID: 17417909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From N-triisopropylsilylpyrrole to an optically active C-4 substituted pyroglutamic acid: total synthesis of penmacric acid.
    Berini C; Pelloux-Léon N; Minassian F; Denis JN
    Org Biomol Chem; 2009 Nov; 7(21):4512-6. PubMed ID: 19830303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis of cyclic tetrapeptide FR235222, a potent immunosuppressant that inhibits mammalian histone deacetylases.
    Xie W; Zou B; Pei D; Ma D
    Org Lett; 2005 Jun; 7(13):2775-7. PubMed ID: 15957944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1.
    Kaur N; Monga V; Lu X; Gershengorn MC; Jain R
    Bioorg Med Chem; 2007 Jan; 15(1):433-43. PubMed ID: 17035026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtually complete control of simple and face diastereoselectivity in the Michael addition reactions between achiral equivalents of a nucleophilic glycine and (S)- or (R)-3-(E-enoyl)-4-phenyl-1,3-oxazolidin-2-ones: practical method for preparation of beta-substituted pyroglutamic acids and prolines.
    Soloshonok VA; Ueki H; Tiwari R; Cai C; Hruby VJ
    J Org Chem; 2004 Jul; 69(15):4984-90. PubMed ID: 15255725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient asymmetric synthesis of novel 4-substituted and configurationally stable analogues of thalidomide.
    Yamada T; Okada T; Sakaguchi K; Ohfune Y; Ueki H; Soloshonok VA
    Org Lett; 2006 Nov; 8(24):5625-8. PubMed ID: 17107088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perpetually self-propelling chiral single crystals.
    Panda MK; Runčevski T; Husain A; Dinnebier RE; Naumov P
    J Am Chem Soc; 2015 Feb; 137(5):1895-902. PubMed ID: 25581716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of N-amidino-pyroglutamic acid into peptides using intramolecular cyclization of alpha-guanidinoglutaric acid.
    Burov S; Moskalenko Y; Dorosh M; Shkarubskaya Z; Panarin E
    J Pept Sci; 2009 Nov; 15(11):760-6. PubMed ID: 19739127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-9-fluorenylmethoxycarbonylpyroglutamate. Preparation of the acid, chloride and succinimidyl ester.
    Benoiton NL; Chen FM
    Int J Pept Protein Res; 1994 Apr; 43(4):321-4. PubMed ID: 8045676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deblocking of proteins containing N-terminal pyroglutamic acid.
    Mozdzanowski J
    Methods Mol Biol; 2003; 211():365-9. PubMed ID: 12489444
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of highly substituted pyroglutamates via a domino Michael addition-Claisen rearrangement-lactamisation approach.
    Schmidt C; Kazmaier U
    Org Biomol Chem; 2008 Dec; 6(24):4643-8. PubMed ID: 19039375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Access to 3-Substituted Pyroglutamic Acids from Tetramate Derivatives of Serine, Threonine,
    Bagum H; Christensen KE; Genov M; Pretsch A; Pretsch D; Moloney MG
    J Org Chem; 2019 Aug; 84(16):10257-10279. PubMed ID: 31287955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastereoselection of chiral acids in a cylindrical capsule.
    Palmer LC; Zhao YL; Houk KN; Rebek J
    Chem Commun (Camb); 2005 Aug; (29):3667-9. PubMed ID: 16027905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvothermal construction of a coordination polymer around in situ generated pyroglutamic acid: preparation, crystal structure, and magnetic behavior of [Mn(C5H6NO3)2]infinity.
    Gutschke SO; Price DJ; Powell AK; Wood PT
    Inorg Chem; 2000 Aug, 7; 39(16):3705-7. PubMed ID: 11196836
    [No Abstract]   [Full Text] [Related]  

  • 20. Diastereoselective Ritter reactions of chiral cyclic N-acyliminium ions: synthesis of pyrido- and pyrrolo[2,3-d]oxazoles and 4-Hydroxy-5-N-acylaminopyrrolidines and 5-hydroxy-6-N-acylaminopiperidines.
    Morgan IR; Yazici A; Pyne SG; Skelton BW
    J Org Chem; 2008 Apr; 73(7):2943-6. PubMed ID: 18307359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.